In vitro P-glycoprotein affinity for atypical and conventional antipsychotics
- 23 April 2002
- journal article
- Published by Elsevier in Life Sciences
- Vol. 71 (2) , 163-169
- https://doi.org/10.1016/s0024-3205(02)01680-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Multidrug-Resistance TransportersPublished by Springer Nature ,2002
- Increased drug delivery to the brain by P-glycoprotein inhibitionClinical Pharmacology & Therapeutics, 2000
- Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoproteinClinical Pharmacology & Therapeutics, 2000
- Biotransformation of Post-Clozapine AntipsychoticsClinical Pharmacokinetics, 2000
- Increased brain P-glycoprotein in morphine tolerant ratsLife Sciences, 1999
- Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug deliveryJournal of Controlled Release, 1999
- Drug metabolism and atypical antipsychoticsEuropean Neuropsychopharmacology, 1999
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of ratPsychopharmacology, 1998
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996